BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21072752)

  • 41. Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis.
    Zhu YJ; Zheng YR; Li L; Zhou H; Liao X; Guo JX; Yi P
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1839-44. PubMed ID: 24422551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
    Kulinska R
    Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noninvasive fetal blood grouping: present and future.
    Daniels G; Finning K; Martin P
    Clin Lab Med; 2010 Jun; 30(2):431-42. PubMed ID: 20513561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preliminary results of fetal Rhc examination in plasma of pregnant women with anti-c.
    Orzińska A; Guz K; Brojer E; Zupańska B
    Prenat Diagn; 2008 Apr; 28(4):335-7. PubMed ID: 18382999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RhD status of a fetus at risk for haemolytic disease with a discrepant maternal DNA-based RhD genotype.
    Denomme GA; Akoury H; Sermer M; Kelton JG
    Prenat Diagn; 1999 May; 19(5):424-7. PubMed ID: 10360510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current status of neonatal hemolytic disease caused by Rh incompatibility].
    Uhlig R; Menzel K
    Z Arztl Fortbild (Jena); 1986; 80(4):143-8. PubMed ID: 3087070
    [No Abstract]   [Full Text] [Related]  

  • 47. Successful perinatal management of hydrops fetalis due to hemolytic disease associated with D-- maternal phenotype.
    Aref K; Boctor FN; Pande S; Uehlinger J; Manning F; Eglowstein M; Mallozzi A; Bebbington M; Weinberg G; Rosen O; Raab C; Brion LP
    J Perinatol; 2002 Dec; 22(8):667-8. PubMed ID: 12478452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype.
    Gardener GJ; Legler TJ; Hyett JA; Liew YW; Flower RL; Hyland CA
    Transfusion; 2012 Sep; 52(9):2016-9. PubMed ID: 22313164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Molecular genetics and clinical application of Rh blood group system].
    Zhang J; Hou Y; Tang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):246-9. PubMed ID: 12048689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women.
    Zhou L; Thorson JA; Nugent C; Davenport RD; Butch SH; Judd WJ
    Am J Obstet Gynecol; 2005 Dec; 193(6):1966-71. PubMed ID: 16325598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Genetic analysis of the fetus using maternal blood].
    Costa JM; Gautier E; Benachi A
    Gynecol Obstet Fertil; 2004; 32(7-8):646-50. PubMed ID: 15450264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fetal blood group genotyping: present and future.
    Daniels G; Finning K; Martin P; Summers J
    Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prenatal determination of the fetal RhD blood group by multiplex PCR: a 7-year Portuguese experience.
    Pereira JC; Couceiro AB; Cunha EM; Machado AI; Tamagnini GP; Martins NP; Ribeiro ML
    Prenat Diagn; 2007 Jul; 27(7):633-7. PubMed ID: 17497744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
    Delaney M; Matthews DC
    Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multiplex PCR for non-invasive fetal RHD genotyping using cell-free fetal DNA.
    Tounta G; Vrettou C; Kolialexi A; Papantoniou N; Destouni A; Tsangaris GT; Antsaklis A; Kanavakis E; Mavrou A
    In Vivo; 2011; 25(3):411-7. PubMed ID: 21576416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An international reference reagent for the detection of RHD and SRY DNA in plasma.
    Metcalfe P; Rigsby P; Tait E; Urbaniak S
    Vox Sang; 2012 Apr; 102(3):243-9. PubMed ID: 21967131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.